Correction: the original version of this article identified this as another recall for Novum IQ. Baxter issued a notification related to a Nov. 15 recall, not a notification for a separate recall. This story has been updated.
Baxter (NYSE:BAX) issued an urgent medical device correction notice regarding its Novum IQ syringe infusion pump.
A few weeks ago, the FDA deemed a Novum IQ recall Class I because the pump may incorrectly indicate the completion of an infusion.
Deerfield, Illinois-based Baxter notified customers of the latest issue in October. This correction comes as a result of the potential for an incomplete infusion following one or more downstream occlusion alarms. The company has work underway on a software upgrade and has not received reports of serious injury related to the issue.
Get the full story at our sister site, Drug Delivery Business News.